Sign in

You're signed outSign in or to get full access.

UC

UNIVERSAL CORP /VA/ (UVV)·Q1 2026 Earnings Summary

Executive Summary

  • Revenue was $593.8M, down $3.3M year over year and down $108.5M versus Q4’s seasonal peak; operating income rose to $33.8M (+$16.6M y/y) on a favorable tobacco mix; diluted EPS was $0.34 vs $0.01 a year ago .
  • Tobacco Operations delivered a sharp improvement in segment operating income (+$21.2M y/y), while Ingredients revenue rose but margins compressed on mix, tariff uncertainty, and higher fixed costs tied to the expanded facility .
  • Management expects flue-cured and burley crop sizes to increase ~25% and ~45% (ex-China) in FY26, moving supply toward balance and potentially into oversupply by year-end; uncommitted tobacco inventory was ~11% at quarter-end, supporting pricing and flexibility .
  • Liquidity strengthened q/q: cash $178.4M (+$76.7M q/q), net debt down $47.1M q/q; ~$355M revolver availability provides additional cushion. Quarterly dividend of $0.82 was declared, payable Nov 3, 2025 .

What Went Well and What Went Wrong

What Went Well

  • Tobacco segment mix drove materially higher profitability: segment operating income rose to $35.7M (+$21.2M y/y), with pricing up ~2% and strong Asia mix despite lower volumes .
  • Low uncommitted inventory (~11%) and more normalized buying patterns enhance flexibility to serve demand and manage margins in a transitioning supply environment .
  • CFO emphasized strengthened balance sheet discipline, with net debt $47M lower than last June and focus on conservative leverage; cash increased to $178.4M .

What Went Wrong

  • Ingredients segment operating income fell to $1.7M from $2.9M y/y, pressured by less favorable mix, tariff uncertainty curtailing some demand, and higher fixed costs as the facility ramps .
  • Consolidated revenues declined modestly y/y (-$3.3M) driven by lower carryover crop tobacco shipments after earlier-than-usual shipments last fiscal year .
  • Seasonal working capital usage increased with green tobacco purchases, resulting in higher short-term debt q/q, even as net debt declined; FX/tariff dynamics remain fluid into the back half .

Financial Results

MetricQ1 2025 (FY25)Q4 2025 (FY25)Q1 2026 (FY26)
Revenue ($USD Millions)$597.1 $702.3 $593.8
Operating Income ($USD Millions)$17.2 $42.8 $33.8
Net Income - Attributable to UVV ($USD Millions)$0.1 $9.3 $8.5
Diluted EPS ($USD)$0.01 $0.37 $0.34
Gross Profit Margin %16.1% 18.65%*19.2%
EBIT Margin %2.89%*6.09%*5.88%*

Values with asterisk retrieved from S&P Global.

Segment breakdown (Q1 2026 vs Q1 2025):

SegmentQ1 2025 Revenue ($M)Q1 2026 Revenue ($M)Q1 2025 Segment OI ($M)Q1 2026 Segment OI ($M)
Tobacco Operations$512.0 $504.7 $14.5 $35.7
Ingredients Operations$85.1 $89.1 $2.9 $1.7

Selected KPIs and balance sheet:

KPIQ1 2026
Tobacco sales volumes changeDown ~8% y/y on lower carryover crop sales
Tobacco sales prices changeUp ~2% on mix
Uncommitted tobacco inventory~11% at quarter end
Cash and cash equivalents$178.4M
Total Debt$1,239.3M
Net Debt$1,065.5M
Revolver availability~$355M
Restructuring & impairment$1.1M (European sheet consolidation)

Non-GAAP:

MetricQ1 2025Q1 2026
Adjusted Operating Income ($M)$17.2 $34.9
Adjusted Diluted EPS ($)$0.01 $0.38

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Flue-cured crop size (ex-China)FY26~+20% (FY26 outlook from Q4 call) ~+25% Raised
Burley crop size (ex-China)FY26~+30% (FY26 outlook from Q4 call) ~+45% Raised
Supply balance outlookFY26Move toward balance/slight oversupply Balance in FY26; likely oversupply by year-end Clarified (more oversupply risk)
CapExFY26$45–$55M Not updated in Q1 materials Maintained (no change)
Interest expenseFY26Target down vs FY25 (working capital normalization) No numeric update; continued focus Maintained (directional)
Dividend per shareOngoing$0.82 declared (Aug payable) $0.82 declared; payable Nov 3, 2025 Maintained
Buyback authorizationOngoing$100M renewed $100M in place; no current plans to use Maintained (inactive)
Tax rateFY26Not providedNot providedN/A

Earnings Call Themes & Trends

TopicPrevious Mentions (Q3 FY25)Previous Mentions (Q4 FY25)Current Period (Q1 FY26)Trend
Tariffs/macroPreliminary impact, FX losses, demand robust; low uncommitted inventory (~10%) Timing shifts; customers expecting lower tobacco costs; active mitigation planning Tariff uncertainty curtailed some Ingredients demand; mitigation via sourcing shifts and forward buys; flexibility across tobacco origins Elevated uncertainty; proactive mitigation
Supply/crop sizesStrong shipments; higher Africa yields; Asia volumes Outlook to more balanced market with larger crops Flue-cured +25%, burley +45% ex-China; likely oversupply by year-end Moving from undersupply → balance/oversupply
Ingredients executionValue-added interest; margins strained in traditional products Platform investment in Lancaster; intent to grow organically Revenues up; OI down on mix/tariffs/fixed costs; focus on converting pipeline Scaling phase; margin rebuild needed
Working capital/net debtCash ~$215M; notes payable ~$539M WC normalization in Brazil; net debt down $180M y/y by Mar 31 Seasonal WC usage increased; cash $178.4M; net debt down $47.1M q/q Improving leverage; seasonal swings
Management changes—CFO retirement plan (search initiated) CFO reiterated retirement timeline; transition through 7/1/26 Stable transition
Sustainability93.5% coal-free processing; farmer training Highlighted sustainability investments Biomass boiler in Zimbabwe; Scope 1/2/3 verification Continuing investment

Management Commentary

  • “We are pleased with our good start for fiscal year 2026… Our Tobacco Operations segment’s improved quarterly performance was driven primarily by a favorable product mix… Customer demand remains firm… uncommitted tobacco inventory levels were low, at about 11%, as of June 30, 2025.” — Preston D. Wigner, CEO .
  • “Our Ingredients Operations segment maintained positive momentum, achieving higher sales volumes… impacted by a less favorable product mix, some curtailed demand due to tariff uncertainty, and higher fixed costs… We are diligently working on converting interest… into increased volumes.” — CEO .
  • “Operating income for the quarter was $33.8 million… The increase… was due to a favorable product mix in the tobacco operations segment… Adjusted net income… was $9.6 million or $0.38 per share.” — CFO .
  • “Given the current expected crop sizes, we believe it is likely that flue-cured and burley tobacco will be in oversupply positions by the end of the fiscal year.” — CEO .
  • “We recently completed our annual third-party assessment and verification of Scope 1, 2, and relevant Scope 3 emissions… the newly commissioned biomass boiler in Zimbabwe… will reduce coal use over time.” — CEO .

Q&A Highlights

  • Tariffs: Management detailed mitigation strategies via origin shifts (e.g., Brazil to U.S. tobacco), diversified customer base, and forward buying for Chinese-sourced inputs; inclusion of tariff costs in pricing depends on customer arrangements .
  • Tobacco margins outlook: Larger crops may lower prices and pressure margins, but higher factory throughput helps unit costs; improved buying patterns and low uncommitted inventory support margin protection .
  • Ingredients margins trajectory: Near-term headwinds from mix and fixed costs; strategy to ramp value-added volumes through the expanded facility and convert pipeline wins; optimistic about back-half improvement but execution required .
  • Seasonality and carryover: Q1 is seasonally small; carryover timing/mix can swing results materially; oversupply risk managed via non-speculative purchasing and inventory discipline .
  • Capital allocation: $100M repurchase authorization renewed but no active plans; priority on strategic investments and delivering results; focus remains on reducing interest expense as WC normalizes .

Estimates Context

  • Wall Street consensus (S&P Global) for Q1 FY26 EPS and revenue was not available/insufficient; no meaningful number of estimates were returned.
  • Target Price Consensus Mean: $78.00* (current snapshot; not period-specific).
    Values retrieved from S&P Global.

Key Takeaways for Investors

  • Tobacco mix-driven profitability and low uncommitted inventory underpin earnings resilience even as supply shifts toward oversupply; monitor margins against expected price declines as crops scale .
  • Ingredients is at an inflection: volumes are growing but margins lag; execution on value-added pipeline through Lancaster capacity is critical for margin normalization in H2/FY26 .
  • Liquidity improved with cash up and net debt down q/q; revolver headroom ~$355M provides flexibility to navigate tariff/supply volatility .
  • Expect near-term narrative focus on tariffs and oversupply management; UVV’s diversified footprint and customer relationships are key catalysts for stable pricing and service expansion .
  • Dividend continuity ($0.82/qtr) and a renewed but inactive buyback suggest a balanced capital return posture while the company prioritizes organic growth and WC discipline .
  • Watch for capex execution ($45–$55M FY26 from prior commentary) and interest expense moderation as WC normalizes; any formal guidance updates could be a stock catalyst .
  • Leadership continuity through CFO transition reduces operational risk; strategic focus remains on maximizing tobacco and scaling ingredients with sustainability investments as a differentiator .